🇺🇸 Sugamadex in United States

7 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 7

Most-reported reactions

1. Atrial Fibrillation — 1 report (14.29%)
2. Conjunctival Oedema — 1 report (14.29%)
3. Drug Effect Decreased — 1 report (14.29%)
4. Drug Interaction — 1 report (14.29%)
5. Eyelid Oedema — 1 report (14.29%)
6. Procedural Hypotension — 1 report (14.29%)
7. Product Quality Issue — 1 report (14.29%)

Source database →

Frequently asked questions

Is Sugamadex approved in United States?

Sugamadex does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Sugamadex in United States?

Ain Shams University is the originator. The local marketing authorisation holder may differ — check the official source linked above.